✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks Investors Are Dumping Right Now

Page 1 of 3

Wall Street kicked off the trading week on a sour note, with all three major indices recording huge losses, amid lingering investor concerns about the fate of artificial intelligence buildout.

The Nasdaq fell the most, slashing 2.49 percent, followed by the S&P 500 declining 1.92 percent. The Dow Jones tumbled 1.41 percent.

Meanwhile, 10 stocks led the session’s fall, slashing more than 9 to 16 percent of their value. In this article, we identified their names and detailed the reasons behind their drop.

To come up with the list, we considered the stocks with more than $1 billion in market capitalization and at least 5 million shares in trading volume.

The New York Stock Exchange building. Photo by Дмитрий Трепольский on Pexels

10. Intuitive Machines Inc. (NASDAQ:LUNR)

Intuitive Machines saw its share price decline by 9.77 percent on Monday to close at $11.73 as investors resorted to profit-taking following last week’s climb to the $13 territory.

This followed its earnings performance in the third quarter of the year and the successful bagging of a new contract from the National Aeronautics and Space Administration (NASA) under its new $10 billion commercial payload services 2, designed to support more capable cargo missions at greater frequency, advancing Artemis and Moon Base infrastructure requirements, including transportation, mobility, power, habitats, and logistics.

Its selection followed its successful CLPS task orders, including two this year.

In March, NASA awarded Intuitive Machines Inc. (NASDAQ:LUNR) a $180.4 million contract for its larger cargo-class Nova-D lunar lander, followed in June by an award valued at up to $148.3 million for a production line-qualified Nova-C lander.

In other news, Intuitive Machines Inc. slashed its net losses attributable to shareholders in the second quarter of the year by 40 percent to $4.19 million from $7 million in the same period last year.

Total revenues soared by 418 percent to $269.3 million from $52.4 million year-on-year, primarily driven by product revenues of $215 million and a 6 percent jump in service revenues at $54 million.

9. Absci Corp. (NASDAQ:ABSI)

Absci Corp. dropped for a third straight day on Monday, slashing 11.54 percent to end at $7.48 apiece after receiving a price target cut for its stock.

In a market note, Guggenheim Securities reduced its price target to $14 from $15 previously, while maintaining a buy recommendation, after technically adjusting its model to a fully diluted share count in its discounted cash flow analysis. It said that the stock may be particularly volatile into and around the December data.

The target cut followed Absci Corp.’s (NASDAQ:ABSI) earnings performance in the third quarter of the year, where it registered a 16 percent higher net loss of $33.3 million versus $28.7 million in the same period last year.

Absci Corp. remains a pre-revenue company, having no commercial sales yet, although it earns from partner programs.

Partner program revenues during the period stood at $304,000 versus $378,000 year-on-year.

Last week, the company named Gerry Muhle as its new chief commercial officer to lead commercialization of prescription medicines and build consumer brands to advance ABS-201 and the company’s broader pipeline.

Muhle brings more than 25 years of commercial leadership experience, having led multiple successful product launches across prescription medicines, aesthetics, and consumer skincare, and held full P&L responsibility for major businesses at his previous companies.

Prior to Absci Corp., Muhle served as Senior Vice President and Head of Global Product Strategy for Galderma, where he led global commercial and product strategy across the company’s entire portfolio, spanning all three businesses: therapeutic dermatology, injectable aesthetics, and dermatological skincare.

8. Strive Inc. (NASDAQ:ASST)

Strive Inc. dropped its share price by 11.94 percent on Monday to finish at $18.81 apiece as investors weighed its move to acquire more Bitcoins for $17.5 million.

In a regulatory filing on the same day, the finance and asset management company said that it boosted its Bitcoin ownership by 251 to a total of 43,404 following a series of acquisitions between November 7 and 13.

This followed another one earlier this month, where it scooped up 124 Bitcoins for around $10 million.

Meanwhile, prices of Bitcoin were down by 0.02 percent on Monday to $65,298 apiece.

In other news, Strive Inc. (NASDAQ:ASST) reported a strong earnings performance in the third quarter of the year, having swung to a net income attributable to shareholders of $474.8 million from a $192.3 million net loss in the same period last year. Total revenues increased by 957 percent to $2.696 million from $255,000 year-on-year, thanks to a 534 percent jump in advisory fees coupled with $1.133 million in revenues from medical devices.

“Strive has continued to successfully execute on its treasury management strategy, delivering a strong Bitcoin yield year to date in 2026, which I believe is the primary driver of our common equity’s outperformance relative to Bitcoin so far this year,” Strive Inc. Chairman and CEO Matthew Cole said.

“We believe Strive has never been in a better position to generate long-term returns in excess of Bitcoin for our common equity shareholders,” he noted.

Page 1 of 3